Treatment outcome predictors for cocaine dependence

American Journal of Drug and Alcohol Abuse

Volumn 33, Issue 2, 2007, Pages 191-206

  Poling, James ^a,c   Kosten, Thomas R ^b   Sofuoglu, Mehmet ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

Clinical trials; Cocaine; Outcome; Predictor

Indexed keywords

ALCOHOL; COCAINE;

ALCOHOL CONSUMPTION; ARTICLE; BRAIN FUNCTION; COCAINE DEPENDENCE; COMORBIDITY; DEPRESSION; DRUG USE; GENETIC POLYMORPHISM; HUMAN; IMPULSIVENESS; PERSONALITY; PREDICTOR VARIABLE; RELAPSE; RISK FACTOR; STRESS; TREATMENT OUTCOME; TREATMENT RESPONSE; WITHDRAWAL SYNDROME;

COCAINE-RELATED DISORDERS; FEMALE; HUMANS; MALE; PROGNOSIS; RISK ASSESSMENT;

EID: 34248597174     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.1080/00952990701199416     Document Type: Article

References (80)

1. United States Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National household survey on drug abuse. DHHS publication; no. (SMA) 96-3079. 2001, Rockville, MD: U.S. Department of Health and Human Services Public Health Service. viii, 127, A-27.
2. Sofuoglu M, Poling J, Gonzalez G, Gonsai K, Kosten T. Cocaine withdrawal symptoms predict medication response in cocaine users. Am J Drug Alcohol Abuse 2006; 32(4):617-627.
3. Griffin ML, Weiss RD, Mirin SM, Lange U. A comparison of male and female cocaine abusers. Arch Gen Psychiatry 1989; 46(2):122-126.
4. Kosten TA, Gawin FH, Kosten TR, Rounsaville BJ. Gender differences in cocaine use and treatment response. J Subst Abuse Treat 1993; 10:63-66.
5. McCance-Katz EF, Carroll KM, Rounsaville BJ. Gender differences in treatment-seeking cocaine abusers-implications for treatment and prognosis. Am J Addict 1999; 8(4):300-311.
6. Weiss RD, Martinez-Raga J, Griffin ML, Greenfield SF, Hufford C. Gender differences in cocaine dependent patients: a 6 month follow-up study. Drug Alcohol Depend 1997; 44(1):35-40.
7. Reiber C, Ramirez A, Parent D, Rawson RA. Predicting treatment success at multiple timepoints in diverse patient populations of cocaine-dependent individuals. Drug Alcohol Depend 2002; 68(1):35-48.
8. Wong CJ, Badger GJ, Sigmon SC, Higgins ST. Examining possible gender differences among cocaine-dependent outpatients. Exp Clin Psychopharmacol 2002; 10(3):316-323.
9. Siqueland L, Crits-Christoph P, Gallop R, Barber JP, Griffin ML, Thase ME, Daley D, Frank A, Gastfriend DR, Blaine J, Connolly MB, Gladis M. Retention in psychosocial treatment of cocaine dependence: predictors and impact on outcome. Am J Addict 2002; 11(1):24-40.
10. Carroll KM, Power ME, Bryant K, Rounsaville BJ. One-year follow-up status of treatment-seeking cocaine abusers. Psychopathology and dependence severity as predictors of outcome. J Nerv Ment Dis 1993; 181(2):71-79.
11. Sofuoglu M, Gonzalez G, Poling J, Kosten TR. Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence. Am J Drug Alcohol Abuse 2003; 29(4):713-727.
12. Alterman AI, McKay JR, Mulvaney FD, McLellan AT. Prediction of attrition from day hospital treatment in lower socioeconomic cocaine-dependent men. Drug Alcohol Depend 1996; 40(3):227-233.
13. Alterman AI, Kampman K, Boardman CR, Cacciola JS, Rutherford MJ, McKay JR, Maany I. A cocaine-positive baseline urine predicts outpatient treatment attrition and failure to attain initial abstinence. Drug Alcohol Depend 1997; 46(1-2):79-85.
14. Ehrman RN, Robbins SJ, Cornish JW. Results of a baseline urine test predict levels of cocaine use during treatment. Drug Alcohol Depend 2001; 62(1):1-7.
15. Patkar AA, Hill KP, Sterling RC, Gottheil E, Berrettini WH, Weinstein SP. Serum prolactin and response to treatment among cocaine-dependent individuals. Addict Biol 2002; 7(1):45-53.
16. Preston KL, Silverman K, Higgins ST, Brooner RK, Montoya I, Schuster CR, Cone EJ. Cocaine use early in treatment predicts outcome in a behavioral treatment program. J Consult Clin Psychol 1998; 66(4):691-696.
17. Higgins ST, Badger GJ, Budney AJ. Initial abstinence and success in achieving longer term cocaine abstinence. Exp Clin Psychopharmacol 2000; 8(3):377-386.
18. American Psychiatric Association. Task Force on DSM-IV, eds. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. 4th ed. 1994. American Psychiatric Association: Washington, DC. xxvii, 886.
19. Schuckit MA, Daeppen JB, Danko GP, Tripp ML, Smith TL, Li TK, Hesselbrock VM, Bucholz KK. Clinical implications for four drugs of the DSM-IV distinction between substance dependence with and without a physiological component. Am J Psychiatry 1999; 156(1):41-49.
20. Sofuoglu M, Dudish-Poulsen S, Brown SB, Hatsukami DK. Association of cocaine withdrawal symptoms with more severe dependence and enhanced subjective response to cocaine. Drug Alcohol Depend 2003; 69(3):273-282.
21. Mulvaney FD, Alterman AI, Boardman CR, Kampman K. Cocaine abstinence symptomatology and treatment attrition. J Subst Abuse Treat 1999; 16(2):129-135.
22. Kampman KM, Alterman AI, Volpicelli JR, Maany I, Muller ES, Luce DD, Mulholland EM, Jawad AF, Parikh GA, Mulvaney FD, Weinrieb RM, O'Brien CP. Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment. Psychol Addict Behav 2001; 15(1):52-59.
23. Kampman KM, Pettinati HM, Volpicelli JR, Oslin DM, Lipkin C, Sparkman T, O'Brien CP. Cocaine dependence severity predicts outcome in outpatient detoxification from cocaine and alcohol. Am J Addict 2004; 13(1):74-82.
24. Kampman KM, Volpicelli JR, Mulvaney F, Alterman AI, Cornish J, Gariti P, Cnaan A, Poole S, Muller E, Acosta T, Luce D, O'Brien C. Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity. Drug Alcohol Depend 2001; 63(1):69-78.
25. Weiss RD, Griffin ML, Hufford C. Craving in hospitalized cocaine abusers as a predictor of outcome. Am J Drug Alcohol Abuse 1995; 21(3):289-301.
26. Dudish-Poulsen SA, Hatsukami DK. Dissociation between subjective and behavioral responses after cocaine stimuli presentations. Drug Alcohol Depend 1997; 47(1):1-9.
27. Bordnick PS, Schmitz JM. Cocaine craving: an evaluation across treatment phases. J Subst Abuse 1998; 10(1):9-17.
28. Weiss RD, Griffin ML, Mazurick C, Berkman B, Gastfriend DR, Frank A, Barber JP, Blaine J, Salloum I, Moras K. The relationship between cocaine craving, psychosocial treatment, and subsequent cocaine use. Am J Psychiatry 2003; 160(7):1320-1325.
29. Carroll KM, Rounsaville BJ, Bryant KJ. Alcoholism in treatment-seeking cocaine abusers: clinical and prognostic significance. J Stud Alcohol 1993; 54(2):199-208.
30. Higgins ST, Budney AJ, Bickel WK, Foerg FE, Badger GJ. Alcohol dependence and simultaneous cocaine and alcohol use in cocaine-dependent patients. J Addict Dis 1994; 13(4):177-189.
31. Raimo EB, Smith TL, Danko GP, Bucholz KK, Schuckit MA. Clinical characteristics and family histories of alcoholics with stimulant dependence. J Stud Alcohol 2000; 61(5):728-735.
32. Schmitz JM, Bordnick PS, Kearney ML, Fuller SM, Breckenridge JK. Treatment outcome of cocaine-alcohol dependent patients. Drug Alcohol Depend 1997; 47(1):55-61.
33. McKay JR, Alterman AI, Rutherford MJ, Cacciola JS, McLellan AT. The relationship of alcohol use to cocaine relapse in cocaine dependent patients in an aftercare study. J Stud Alcohol 1999; 60(2):176-180.
34. Khalsa H, Paredes A, Anglin MD. The role of alcohol in cocaine dependence. Recent Dev Alcohol 1992; 10:7-35.
35. Brower KJ, Blow FC, Hill EM, Mudd SA. Treatment outcome of alcoholics with and without cocaine disorders. Alcohol Clin Exp Res 1994; 18(3):734-9.
36. Patkar AA, Murray HW, Mannelli P, Gottheil E, Weinstein SP, Vergare MJ. Pre-treatment measures of impulsivity, aggression and sensation seeking are associated with treatment outcome for African-American cocaine-dependent patients. J Addict Dis 2004; 23(2):109-122.
37. Mengis MM, Maude-Griffin PM, Delucchi K, Hall SM. Alcohol use affects the outcome of treatment for cocaine abuse. Am J Addict 2002; 11(3): 219-27.
38. Richter KP, Ahluwalia HK, Mosier MC, Nazir N, Ahluwalia JS. A population-based study of cigarette smoking among illicit drug users in the United States. Addiction 2002; 97(7):861-869.
39. Roll JM, Higgins ST, Budney AJ, Bickel WK, Badger GJ. A comparison of cocaine-dependent cigarette smokers and non-smokers on demographic, drug use and other characteristics. Drug Alcohol Depend 1996; 40(3):195-201.
40. Patkar AA, Vergare MJ, Thornton CC, Weinstein SP, Murray HW, Leone FT. Nicotine dependence and treatment outcome among African American cocaine-dependent patients. Nicotine Tob Res 2003; 5(3):411-418.
41. Rounsaville BJ, Anton SF, Carroll K, Budde D, Prusoff BA, Gawin F. Psychiatric diagnosis of treatment-seeking cocaine abusers. Arch Gen Psychiatry 1991; 18(1):43-51.
42. Brown RA, Monti PM, Myers MG, Martin RA, Rivinus T, Dubreuil ME, Rohsenow DJ. Depression among cocaine abusers in treatment: relation to cocaine and alcohol use and treatment outcome. Am J Psychiatry 1998; 155(2):220-225.
43. Hasin D, Liu X, Nunes E, McCloud S, Samet S, Endicott J. Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry 2002; 59(4):375-380.
44. McKay JR, Pettinati HM, Morrison R, Feeley M, Mulvaney FD, Gallop R. Relation of depression diagnoses to 2-year outcomes in cocaine-dependent patients in a randomized continuing care study. Psychol Addict Behav 2002; 16(3):225-235.
45. Uslaner J, Kalechstein A, Richter T, Ling W, Newton T. Association of depressive symptoms during abstinence with the subjective high produced by cocaine. Am J Psychiatry 1999; 156(9):1444-1446.
46. Sofuoglu M, Brown S, Babb DA, Hatsukami DK. Depressive symptoms modulate the subjective and physiological response to cocaine in humans. Drug Alcohol Depend 2001; 63(2):131-137.
47. Ziedonis DM, Kosten TR. Depression as a prognostic factor for pharmacological treatment of cocaine dependence. Psychopharmacol Bull 1991; 27(3):337-343.
48. Gonzalez G, Feingold A, Oliveto A, Gonsai K, Kosten TR. Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management. Am J Drug Alcohol Abuse 2003; 29(3):497-514.
49. King VL, Kidorf MS, Stoller KB, Carter JA, Brooner RK. Influence of antisocial personality subtypes on drug abuse treatment response. J Nerv Ment Dis 2001; 189(9):593-601.
50. Arndt IO, McLellan AT, Dorozynsky L, Woody GE, O'Brien CP. Desipramine treatment for cocaine dependence. Role of antisocial personality disorder. J Nerv Ment Dis 1994; 182(3):151-156.
51. Leal J, Ziedonis D, Kosten T. Antisocial personality disorder as a prognostic factor for pharmacotherapy of cocaine dependence. Drug Alcohol Depend 1994; 35(1):31-35.
52. McKay JR, Alterman AI, Cacciola JS, Mulvaney FD, O'Brien, CP. Prognostic significance of antisocial personality disorder in cocaine-dependent patients entering continuing care. J Nerv Ment Dis 2000; 188(5):287-296.
53. Messina N, Farabee D, Rawson R. Treatment responsivity of cocaine-dependent patients with antisocial personality disorder to cognitive-behavioral and contingency management interventions. J Consult Clin Psychol 2003; 71(2):320-329.
54. de Wit H, Richards JB. Dual determinants of drug use in humans: reward and impulsivity. Nebr Symp Motiv 2004; 50:19-55.
55. Moeller FG, Dougherty DM, Barratt ES, Schmitz JM, Swann AC, Grabowski J. The impact of impulsivity on cocaine use and retention in treatment. J Subst Abuse Treat 2001; 21(4):193-198.
56. Patkar AA, Mannelli P, Certa KM, Peindl K, Murray H, Vergare MJ, Berrettini WH. Relationship of serum prolactin with severity of drug use and treatment outcome in cocaine dependence. Psychopharmacology (Berl) 2004; 3:3.
57. Helmus TC, Downey KK, Arfken CL, Henderson MJ, Schuster CR. Novelty seeking as a predictor of treatment retention for heroin dependent cocaine users. Drug Alcohol Depend 2001; 61(3):287-295.
58. Roll JM, Saules KK, Chudzynski JE, Sodano R. Relationship between Tridimensional Personality Questionnaire scores and clinic attendance among cocaine abusing, buprenorphine maintained outpatients. Subst Use Misuse 2004; 39(6):1025-1040.
59. Goffin V, Binart N, Touraine P, Kelly PA. Prolactin: the new biology of an old hormone. Annu Rev Physiol 2002; 64:47-67.
60. Wilkins JN, Majewska MD, Van Gorp W, Li SH, Hinken C, Plotkin D, Setoda D. DHEAS and POMS measures identify cocaine dependence treatment outcome. Psychoneuroendocrinology 2005; 30(1):18-28.
61. Reddy DS. Pharmacology of endogenous neuroactive steroids. Crit Rev Neurobiol 2003; 15(3-4):197-234.
62. Glei DA, Goldman N, Weinstein M, Liu IW. Dehydroepiandrosterone sulfate (DHEAS) and health: does the relationship differ by sex? Exp Gerontol 2004; 39(3):321-331.
63. Shoptaw S, Majewska MD, Wilkins J, Twitchell G, Yang X, Ling W. Participants receiving dehydroepiandrosterone during treatment for cocaine dependence show high rates of cocaine use in a placebo-controlled pilot study. Exp Clin Psychopharmacol 2004; 12(2):126-135.
64. Sinha R, Fuse T, Aubin LR, O'Malley S. Psychological stress, drug-related cues and cocaine craving. Psychopharmacology (Berl) 2000; 152(2):140-148.
65. Stewart J. Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking. J Psychiatry Neurosci 2000; 25(2):125-136.
66. Smith JW, Frawley PJ. Treatment outcome of 600 chemically dependent patients treated in a multimodal inpatient program including aversion therapy and pentothal interviews. J Subst Abuse Treat 1993; 10(4):359-369.
67. Sinha R, Talih M, Malison RM, Anderson G, Kreek M. Significant Association between Neurobiological and Cognitive Responses to Stress and Cocaine Relapse. 2004.
68. Carroll KM, Nich C, Ball SA, McCance E, Rounsaville BJ. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction 1998; 93(5):713-727.
69. George TP, Chawarski MC, Pakes J, Carroll KM, Kosten TR, Schottenfeld RS. Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial. Biol Psychiatry 2000; 47(12):1080-1086.
70. Petrakis IL, Carroll KM, Nich C, Gordon LT, McCance-Katz EF, Frankforter T, Rounsaville BJ. Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts. Addiction 2000; 95(2):219-228.
71. Carroll KM, Fenton LR, Ball SA, Nich C, Frankforter TL, Shi J, Rounsaville BJ. Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. Arch Gen Psychiatry 2004; 61(3):264-272.
72. Koob GF, Caine SB, Parsons L, Markou A, Weiss F. Opponent process model and psychostimulant addiction. Pharmacol Biochem Behav 1997; 57(3):513-521.
73. Cubells JF, Kranzler HR, McCance-Katz E, Anderson GM, Malison RT, Price LH, Gelernter J. A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Mol Psychiatry 2000; 5(1):56-63.
74. Breiter HC, Gollub RL, Weisskoff RM, Kennedy DN, Makris N, Berke JD, Goodman JM, Kantor HL, Gastfriend DR, Riorden JP, Mathew RT, Rosen BR, Hyman SE. Acute effects of cocaine on human brain activity and emotion. Neuron 1997; 19(3):591-611.
75. Garavan H, Pankiewicz J, Bloom A, Cho JK, Sperry L, Ross TJ, Salmeron BJ, Risinger R, Kelley D, Stein EA. Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry 2000; 157(11):1789-1798.
76. Wexler BE, Gottschalk CH, Fulbright RK, Prohovnik I, Lacadie CM, Rounsaville BJ, Gore JC. Functional magnetic resonance imaging of cocaine craving. Am J Psychiatry 2001; 158(1):86-95.
77. Kilts CD, Gross RE, Ely TD, Drexler KP. The neural correlates of cue-induced craving in cocaine-dependent women. Am J Psychiatry 2004; 161(2):233-241.
78. Braus DF, Wrase J, Grusser S, Hermann D, Ruf M, Flor H, Mann K, Heinz A. Alcohol-associated stimuli activate the ventral striatum in abstinent alcoholics. J Neural Transm 2001; 108(7):887-894.
79. Grusser SM, Wrase J, Klein S, Hermann D, Smolka MN, Ruf M, Weber-Fahr W, Flor H, Mann K, Braus DF, Heinz A. Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics. Psychopharmacology (Berl) 2004; 175(3):296-302.
80. Kosten TR, Scanley BE, Tucker KA, Oliveto A, Prince C, Sinha R, Potenza MN, Skudlarski P, Wexler BE. Cue-induced brain activity changes and relapse in cocaine dependent patients. Neuropsychopharmacology 2006; 31:644-650.